Our findings align with studies advocating investigation into alternative biological mechanisms, beyond Aβ and tau, in aging and preclinical AD, which show apparent changes linked to subtle disturbances in episodic memory, even in CU late middle‐aged individuals (Malek‐Ahmadi et al. 2023). Here, MAPT is linked to Alzheimer disease.